hepatitis C

The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection.

Leave a Comment / Blogger, Uncategorized / By

For Immediate Release October 10, 2014 Release The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection. Harvoni is the first combination pill approved to treat chronic HCV genotype 1 infection. It is also the first approved regimen that does not require administration …

The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection. Read More »

Activists Condemn Gilead for Exhorbitant Price of Their New Hepatitis C Drug

Leave a Comment / Blogger, Uncategorized / By

For Immediate Release December 9, 2013 Contact: Lynda Dee 410-332-1170 or lyndamdee@aol.com Fair Pricing Coalition Condemns Gilead Sciences on the High Price of New Hepatitis C Drug Sovaldi™, and Urges Rapid and Wide Dissemination of Support Program Details for Uninsured and Underinsured People Living with Hepatitis C The Fair Pricing Coalition (FPC) today condemned Gilead …

Activists Condemn Gilead for Exhorbitant Price of Their New Hepatitis C Drug Read More »

Two companies have an effective 100% cure for Hepatitis C without interferon or ribavirin. But this cure is literally being withheld from millions

Leave a Comment / Blogger, Uncategorized / By

Two companies have an effective 100% cure for Hepatitis C without interferon or ribavirin.  But this cure is literally being withheld from millions by pharmaceutical giant Gilead Sciences because they are more concerned about profits than human lives. This cure is a combination Bristol-Myers Squibb’s drug daclatasvir and Gilead Science’s GS-7977 (sofosbuvir). When these two drugs were used together, 100 …

Two companies have an effective 100% cure for Hepatitis C without interferon or ribavirin. But this cure is literally being withheld from millions Read More »

Merck’s Cavalier Attitude Towards the Welfare of HIV/HCV Coinfected Patients

Leave a Comment / Blogger, Uncategorized / By

What You Don’t Know, You Can Selltagline Spring 2012<https://www.treatmentactiongroup.org/tagline/2012/spring/tagline/2012/spring>by Tracy SwanIn places where access to antiretroviral therapy is widespread, peopleliving with HIV are now dying from a common and curable coinfection:hepatitis C virus (HCV). HIV increases the risk for, and accelerates therate of, liver disease from hepatitis C. Pegylated interferon andribavirin, medications used to treat …

Merck’s Cavalier Attitude Towards the Welfare of HIV/HCV Coinfected Patients Read More »